Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at... GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story
    Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025
     GlobeNewswire
    Full Story →

    Headline News
    Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
    4:01p ET July 9 '25 GlobeNewswire
    Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025
    7:00a ET July 7 '25 GlobeNewswire
    Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
    6:59a ET July 2 '25 GlobeNewswire
    More News →
    Day  3.52%Week  15.2%Month  18.3%More Charting →
    July 11 '25. Markets Closed.
    Last $40.87
    Day change   3.52%$1.49
    Open $42.25
    Gap at open $0.11
    Previous close $42.36
    Trading volume 614,663
    10 Day avg vol. 814,138
    Shares out. 7.4Mil
    Market cap. $300.7Mil
    Trading activity Below Avg.
    Previous data from yesterday, July 10 '25.

    Historical Price Performance
    3 month   142% 
    6 month   59.40% 
    1 year   32.03% 
    2 year   99.31% 

    Earnings
    Previous 12m -$1,963.91
    Next 12m Estimate -$12.26
    P/E ratio --
    Revenue 10Mil

    Market data provided by News provided by